Phocas Financial Corp. Purchases 66,863 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• Phocas Financial Corp. increased its holdings in Acadia Healthcare by 70.9%, acquiring an additional 66,863 shares and now owning a total of 161,183 shares valued at approximately $4.89 million.
• Several hedge funds also boosted their positions in Acadia Healthcare, with FMR LLC leading with a 257.9% increase, acquiring over 4.4 million shares worth about $247 million.
• Research firms have given Acadia Healthcare a consensus rating of "Moderate Buy" with a current price target of $47.94, despite some recent downgrades in price objectives from various analysts.

Phocas Financial Corp. raised its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 70.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 161,183 shares of the company's stock after purchasing an additional 66,863 shares during the quarter. Phocas Financial Corp. owned 0.17% of Acadia Healthcare worth $4,887,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Quadrant Capital Group LLC grew its holdings in Acadia Healthcare by 287.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock worth $50,000 after purchasing an additional 933 shares during the period. UMB Bank n.a. boosted its position in Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares during the last quarter. State of Wyoming bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at $56,000. Covestor Ltd lifted its position in shares of Acadia Healthcare by 27.2% during the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after buying an additional 310 shares in the last quarter. Finally, Aquatic Capital Management LLC purchased a new position in shares of Acadia Healthcare during the 4th quarter valued at $97,000.

Acadia Healthcare Trading Up 1.0%

Shares of NASDAQ ACHC traded up $0.18 during midday trading on Thursday, hitting $18.18. The stock had a trading volume of 1,068,795 shares, compared to its average volume of 2,169,184. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.72. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $82.40. The company has a fifty day moving average price of $22.34 and a 200 day moving average price of $28.23. The company has a market capitalization of $1.67 billion, a price-to-earnings ratio of 12.02, a PEG ratio of 4.15 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.36% and a net margin of 4.31%. Acadia Healthcare's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 EPS. On average, analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Stephens upgraded Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. KeyCorp decreased their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Guggenheim reduced their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a report on Thursday. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday. Finally, Barclays cut their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Thursday. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $46.28.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.